A composition containing at least one yeast for the prevention of simple and/or recurring cystitis such as cystitis caused by uropathogenic Escherichia coli bacteria. The yeast may be in the form of a live yeast, a dead yeast, yeast cell walls, purified fractions of yeast cell walls or mixtures thereof.

A composition containing at least one yeast for the prevention of simple and/or recurring cystitis such as cystitis caused by uropathogenic Escherichia coli bacteria. The yeast may be in the form of a live yeast, a dead yeast, yeast cell walls, purified fractions of yeast cell walls or mixtures thereof.

The subject invention provides methods for cultivating Starmerella bombicola yeasts for sophorolipid production, as well as a yeast fermentation product comprising supernatant, yeast cell biomass and other residual growth by-products that result when the sophorolipids are harvested. Methods of using this yeast fermentation product in animal feed, bioremediation, mining and/or bioleaching, agriculture, oil and gas recovery, human health, and many other applications, are also provided.

Described are compositions and methods relating to formulations and process conditions for stabilizing microorganisms for extended storage under ambient conditions without refrigeration, humidity control, or special packaging.

Described are compositions and methods relating to formulations and process conditions for stabilizing microorganisms for extended storage under ambient conditions without refrigeration, humidity control, or special packaging.

Methods for treatment and compositions are provided for increasing the health of humans, livestock, and companion animals. More particularly, dietary supplements (also referred to as PPA (prebiotic, probiotic, antibodies) compositions) for treating humans, livestock, and companion animals, and methods for making and using them for treatment of various conditions are disclosed.

Methods for treatment and compositions are provided for increasing the health of humans, livestock, and companion animals. More particularly, dietary supplements (also referred to as PPA (prebiotic, probiotic, antibodies) compositions) for treating humans, livestock, and companion animals, and methods for making and using them for treatment of various conditions are disclosed.

The present invention describes a syrup of tagatose and galactose as main components together with other secondary products such as glycerol, oligosaccharides and other sugars in a minority amount.

According to exemplary embodiments, provided herein are methods for nutrient fortification, including determining a nutrient profile for a first food product, modeling a micronutrient profile based on the nutrient profile, culturing yeast in the micronutrient profile and applying the cultured yeast to a second food product.

According to exemplary embodiments, provided herein are methods for nutrient fortification, including determining a nutrient profile for a first food product, modeling a micronutrient profile based on the nutrient profile, culturing yeast in the micronutrient profile and applying the cultured yeast to a second food product.